Overview

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Dey
Treatments:
Formoterol Fumarate
Criteria
Inclusion Criteria:

- Medical diagnosis of COPD

- Current or prior history of cigarette smoking

Exclusion Criteria:

- Medical diagnosis of asthma

- Chest X-ray diagnostic of significant disease other than COPD

- Significant condition or disease other than COPD